BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31628816)

  • 1. Hyperglycemia-induced ubiquitination and degradation of β-catenin with the loss of platelet endothelial cell adhesion molecule-1 in retinal endothelial cells.
    Eshaq RS; Harris NR
    Microcirculation; 2020 Feb; 27(2):e12596. PubMed ID: 31628816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) in the Diabetic Retina: Role of Matrix Metalloproteinases.
    Eshaq RS; Harris NR
    Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):748-760. PubMed ID: 30793207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumor necrosis factor-α and interferon-γ in the hyperglycemia-induced ubiquitination and loss of platelet endothelial cell adhesion molecule-1 in rat retinal endothelial cells.
    Eshaq RS; Harris NR
    Microcirculation; 2021 Oct; 28(7):e12717. PubMed ID: 34008903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia-induced effects on glycocalyx components in the retina.
    Kaur G; Rogers J; Rashdan NA; Cruz-Topete D; Pattillo CB; Hartson SD; Harris NR
    Exp Eye Res; 2021 Dec; 213():108846. PubMed ID: 34801534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation.
    Biswas P; Canosa S; Schoenfeld D; Schoenfeld J; Li P; Cheas LC; Zhang J; Cordova A; Sumpio B; Madri JA
    Am J Pathol; 2006 Jul; 169(1):314-24. PubMed ID: 16816383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
    Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
    Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia-induced VEGF and ROS production in retinal cells is inhibited by the mTOR inhibitor, rapamycin.
    Kida T; Oku H; Osuka S; Horie T; Ikeda T
    Sci Rep; 2021 Jan; 11(1):1885. PubMed ID: 33479328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
    Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina.
    Qiu Y; Zhao D; Butenschön VM; Bauer AT; Schneider SW; Skolnik EY; Hammes HP; Wieland T; Feng Y
    Acta Diabetol; 2016 Feb; 53(1):81-9. PubMed ID: 25900369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
    Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
    Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethanol extract of Zingiber zerumbet rhizomes mitigates vascular lesions in the diabetic retina.
    Hong TY; Tzeng TF; Liou SS; Liu IM
    Vascul Pharmacol; 2016 Jan; 76():18-27. PubMed ID: 26319672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL2 disrupts the adherens junction: implications for neuroinflammation.
    Roberts TK; Eugenin EA; Lopez L; Romero IA; Weksler BB; Couraud PO; Berman JW
    Lab Invest; 2012 Aug; 92(8):1213-33. PubMed ID: 22641100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Nox4 upregulation on PECAM-1 expression in a mouse model of diabetic retinopathy.
    Wang J; Lai DA; Wang JJ; Zhang SX
    PLoS One; 2024; 19(5):e0303010. PubMed ID: 38748682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between reticular adherens junctions and platelet endothelial cell adhesion molecule-1 regulates endothelial barrier function.
    Fernández-Martín L; Marcos-Ramiro B; Bigarella CL; Graupera M; Cain RJ; Reglero-Real N; Jiménez A; Cernuda-Morollón E; Correas I; Cox S; Ridley AJ; Millán J
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):e90-102. PubMed ID: 22723439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM25 inhibition attenuates inflammation, senescence, and oxidative stress in microvascular endothelial cells induced by hyperglycemia.
    Sun D; Li S; Chen S; Zhang S; Gu Q; Shen Y; Wei F; Wang N
    Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):81-91. PubMed ID: 37367995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PECAM-1 drives β-catenin-mediated EndMT via internalization in colon cancer with diabetes mellitus.
    Wu Q; Du X; Cheng J; Qi X; Liu H; Lv X; Gong X; Shao C; Wang M; Yue L; Yang X; Li S; Zhang Y; Li X; Yang H
    Cell Commun Signal; 2023 Aug; 21(1):203. PubMed ID: 37580771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
    Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
    Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.